SF3B1 and myelodysplastic syndrome: The WHO diagnostic criteria also exclude cases with CSF3R mutations and those categorized as MDS/MPN with ring sideroblasts and thrombocytosis (MDS/MPN−RS−T) with SF3B1 mutations.